Patento informacija

EN | LT

LT - 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

EN - 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys

Tarptautinės patentų klasifikacijos indeksai (TPK)
(51)	INT.CL.	C07D 207/14
		C07D 403/12
		C07D 403/14
		C07D 401/14
		C07D 405/14
		C07D 413/14
		A61K 31/40
		A61P 3/06

Europos patentas
(11)	Patento numeris	2404901
(13)	Dokumento rūšis	T
(96)	Europos patento paraiškos numeris	11184000.5
	Europos patento paraiškos padavimo data	2008-12-01
(97)	Europos patento paraiškos paskelbimo data	2012-01-11
(45)	Paskelbimo apie Europos patento išdavimą data	2013-05-22
(46)	Apibrėžties vertimo paskelbimo data

Prioriteto paraiškos
(30)	Numeris	Data	Šalis
	991891 P	2007-12-03	US

Išradėjai
(72)	Mogi, Muneto, US Kawanami, Toshio, US Yamada, Ken, US Yasoshima, Kayo, US Imase, Hidetomo, US Miyake, Takahiro, JP Ohmori, Osamu, JP

Savininkas
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Pavadinimas
(54)	1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
	1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis